The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2020

Filed:

Dec. 19, 2014
Applicants:

Novartis Ag, Basel, CH;

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Gregory Beatty, Philadelphia, PA (US);

Boris Engels, Cambridge, MA (US);

Neeraja Idamakanti, Cambridge, MA (US);

Carl H. June, Merion Station, PA (US);

Andreas Loew, Cambridge, MA (US);

Huijuan Song, Shanghai, CN;

Qilong Wu, Shanghai, CN;

Assignees:

Novartis AG, Basel, CH;

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/30 (2006.01); C07K 14/725 (2006.01); C12N 15/86 (2006.01); A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); C07K 14/705 (2006.01); C07K 14/715 (2006.01); C12N 5/0783 (2010.01); C12N 15/85 (2006.01); A61K 38/00 (2006.01); A61K 31/436 (2006.01);
U.S. Cl.
CPC ...
C07K 16/30 (2013.01); A61K 31/436 (2013.01); A61K 38/1774 (2013.01); A61K 38/1793 (2013.01); A61K 39/0011 (2013.01); A61K 39/39558 (2013.01); A61K 48/0058 (2013.01); C07K 14/7051 (2013.01); C07K 14/70517 (2013.01); C07K 14/7151 (2013.01); C07K 16/303 (2013.01); C07K 16/3061 (2013.01); C07K 16/3069 (2013.01); C12N 5/0638 (2013.01); C12N 15/85 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/5158 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/73 (2013.01); C07K 2317/92 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/74 (2013.01); C12N 2740/15041 (2013.01);
Abstract

Provided are compositions and methods for treating diseases associated with expression of mesothelin. Also provided are a chimeric antigen receptor(CAR) specific to mesothelin, vectors encoding the same, and recombinant T cells comprising the mesothelin CAR. Further provided are methods of administering a genetically modified T cell expressing a CAR that comprises a mesothelin binding domain.


Find Patent Forward Citations

Loading…